Advancing Metabolic Health Through Clinical Research Studies

At Los Angeles Institute for Metabolic Research, we conduct clinical research studies focused on metabolic diseases that affect millions of people, including diabetes, obesity, metabolic liver disease, and hypertension.

Our research studies evaluate investigational therapies and new approaches designed to improve health outcomes. Participation is voluntary, and all studies are conducted under Institutional Review Board (IRB) oversight.

Whether you are newly diagnosed, living with a chronic condition, or simply interested in learning more, we invite you to explore our current clinical research opportunities.

Patrick Smith Patrick Smith

TYPE 2 DIABETES (T2D)

More than 38 million Americans are living with T2D, and about 1 in 5 don’t know they have it. It develops when the body becomes resistant to insulin or doesn’t make enough of it, leading to high blood sugar.

Click "Read More" below for more information on our ongoing and upcoming T2D clinical studies.

Read More
Patrick Smith Patrick Smith

TYPE 1 DIABETES (T1D)

Learn more about our latest TYPE 1 DIABETES (T1D) Clinical Research Trial beginning in April 2026.

Read More